Effervescent tablet
The present invention relates to an effervescent tablet, which upon dissolution in water provides a solution useful as a mouth wash or oral rinse for the prevention or treatment of inflammatory processes of the soft tissues of the mouth, throat and oral cavity.
1. An effervescent tablet comprising:
a) a pharmaceutically effective amount of one or more sodium phosphate salts;
b) a pharmaceutically effective amount of calcium chloride;
c) one or more effervescing organic acid component; and
d) one or more effervescing base component;
wherein said tablet upon dissolution in 50 mL of water provides a supersaturated solution of calcium and phosphate ions, wherein the concentration of calcium ions provided in the obtained supersaturated solution upon dissolution of the effervescent tablet in the 50 mL of water is 2.5-16 mM, and wherein the concentration of phosphate ions provided in the obtained supersaturated solution upon dissolution of the effervescent tablet in the 50 mL of water is 1.5-10 mM,
wherein the tablet upon dissolution in 50 mL of water results in a solution that remains clear for at least 15 minutes.
2. The effervescent tablet according to claim 1 , wherein the tablet comprises a pharmaceutically effective amount of dibasic sodium phosphate and monobasic sodium phosphate.
3. The effervescent tablet according to claim 1 , wherein the effervescing organic acid component is selected from the group consisting of organic mono-, di- and tricarboxylic acids, and oxyacids, salts of organic acids and salts of inorganic acids, and combinations thereof.
4. The effervescent tablet according to claim 3 , wherein the effervescing organic acid component is citric acid.
5. The effervescent tablet according to claim 1 , wherein the one or more effervescing base components is a carbonate salt.
6. The effervescent tablet according to claim 5 , wherein the one or more effervescing bases is selected from the group consisting of sodium carbonate, magnesium carbonate, sodium hydrogen carbonate, potassium carbonate, potassium hydrogen carbonate, calcium carbonate and magnesium carbonate.
7. The effervescent tablet according to claim 6 , wherein composition comprises sodium carbonate and sodium hydrogen carbonate.
8. The effervescent tablet according to claim 1 , wherein the tablet upon dissolution in water results in a solution of about pH 6.5.
9. The effervescent tablet according to claim 1 , wherein the tablet upon dissolution results in a solution remaining clear for at least about 2 hr.
10. The effervescent tablet according to claim 1 , wherein the tablet comprises one or more additional excipients.
11. The effervescent tablet according to claim 10 , wherein the additional excipient is one or more carbohydrates selected from the group consisting of polyalcohols, dextrines and saccharides.
12. The effervescent tablet according to claim 10 , wherein the additional excipient is one or more polyalcohol selected from the group consisting of sorbitol, mannitol, xylitol, and inositol or the mixture thereof.
13. The effervescent tablet according to claim 10 , wherein the additional excipient is one or more saccharides selected from the group consisting of glucose, fructose and sucrose, or the mixture thereof.
14. The effervescent tablet according to claim 10 , wherein the excipient is a flavour and/or sweetener.
15. The effervescent tablet according to claim 10 , wherein the flavour and/or sweetener is selected from the group consisting of saccharin, aspartame, and acesulfame.
16. The effervescent tablet according to claim 1 , wherein the amount of calcium per tablet is in the range of about 14-24 mg.
17. The effervescent tablet according to claim 1 , wherein the amount of phosphate per tablet is in the range of about 28-36 mg.
18. The effervescent tablet according to claim 1 , wherein the tablet comprises a molar ratio of NaH 2 PO 4 :Na 2 HPO 4 :CaCl 2 ×2H 2 O of about 1:3:6.
19. The effervescent tablet according to claim 1 , comprising:
about 69.1 mg calcium chloride dihydrate;
about 9.2 mg monobasic sodium phosphate;
about 31.1 mg dibasic sodium phosphate;
about 450.0 mg sodium hydrogen carbonate;
about 50.0 mg sodium carbonate;
about 238.5 mg citric acid;
about 225.5 mg maltodextrine; and
about 26.5 mg sorbitol.
20. The effervescent tablet according to claim 1 , comprising:
about 69.1 mg calcium chloride dihydrate;
about 9.2 mg monobasic sodium phosphate;
about 31.1 mg dibasic sodium phosphate;
about 512.3 mg sodium hydrogen carbonate;
about 60.6 mg sodium carbonate;
about 272.7 mg citric acid;
about 214.6 mg maltodextrine; and
about 30.3 mg sorbitol.
21. The effervescent tablet according to claim 1 , comprising:
about 69.1 mg calcium chloride dihydrate;
about 9.2 mg monobasic sodium phosphate;
about 31.1 mg dibasic sodium phosphate;
about 1690.5 mg sodium hydrogen carbonate;
about 200.0 mg sodium carbonate;
about 900.0 mg citric acid; and
about 100.0 mg sorbitol.
22. A process for the preparation of effervescent tablets according to claim 1 , comprising the steps of:
a) mixing the one or more effervescing organic acid components and a diluent to provide a mixture;
b) subjecting the mixture of step a) to granulation to provide a granulate;
c) drying the granulate obtained in step b) to provide a dried granulate;
d) mixing the dried granulate of step c) with the one or more effervescing base component, a pharmaceutically effective amount of one or more phosphate salt(s), a pharmaceutically effective amount of a calcium salt, and optionally one or more pharmaceutically acceptable excipients; and
e) compressing the mixture of step d) to form tablets.
23. A process for preventing or treating inflammatory processes of the soft tissues of the mouth, throat and oral cavity, comprising the steps of diluting an effervescent tablet according to claim 1 in a suitable amount of water in order to dissolve the tablet, and administering the obtained solution to the patient as an oral rinse.
24. The effervescent tablet according to claim 1 , wherein the tablet upon dissolution results in a solution remaining clear for at least about 30 minutes.
25. The effervescent tablet according to claim 1 , wherein the tablet upon dissolution results in a solution remaining clear for at least about 60 minutes.